Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

BB Biotech’s Koller asks what lies ahead for M&A activity in the biotech sector? Read more on Wealth DFM.

Coveted drivers of innovation.

BB Biotech’s Koller asks what lies ahead for M&A activity in the biotech sector? Read more on Wealth DFM.
29.06.2022 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993